STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $334,000 | -5.4% | 28,410 | +16.6% | 0.01% | 0.0% |
| Q1 2015 | $353,000 | -9.9% | 24,370 | +6.0% | 0.01% | 0.0% |
| Q4 2014 | $392,000 | +8.9% | 22,980 | -20.6% | 0.01% | +16.7% |
| Q3 2014 | $360,000 | -36.7% | 28,930 | -25.5% | 0.01% | -33.3% |
| Q2 2014 | $569,000 | – | 38,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 579,800 | $7,224,000 | 1.01% |
| VHCP Management, LLC | 71,000 | $884,000 | 0.40% |
| Healthcare Value Capital, LLC | 16,464 | $205,000 | 0.20% |
| CARL DOMINO INC | 22,196 | $277,000 | 0.15% |
| TFS CAPITAL LLC | 120,112 | $1,497,000 | 0.13% |
| Private Capital Advisors, Inc. | 31,064 | $387,000 | 0.12% |
| Artal Group S.A. | 170,000 | $2,118,000 | 0.08% |
| TimesSquare Capital Management, LLC | 801,225 | $9,983,000 | 0.06% |
| Baker Brothers Advisors | 338,671 | $4,220,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 19,399 | $242,000 | 0.04% |